The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.
© Thomson Reuters 2021.Daiichi Sankyo halts trials of existing drug for COVID-19 treatment
TOKYO©2024 GPlusMedia Inc.
The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.
© Thomson Reuters 2021.
3 Comments
Login to comment
Jonathan Prin
Happening to most existing drugs...
virusrex
Which can be understood as not showing enough efficacy even at high doses close to what is considered the limits of safety. No real mystery. The same is what is likely happening with the Anges vaccine.